News about "Syngene International "

Syngene Strengthens Leadership Team with Two Key Appointments

Syngene Strengthens Leadership Team with Two Key Appointments

Maninder Kapoor Puri joins Syngene as Chief Human Resources Officer (CHRO) and Abhijit Zutshi as Chief Commercial Officer (CCO)

Syngene International | 01/05/2026 | By News Bureau

Syngene Partners with Johns Hopkins University for Early Drug Discovery

Syngene Partners with Johns Hopkins University for Early Drug Discovery

The collaboration between Syngene International and John Hopkins University is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research.

Syngene International | 13/02/2026 | By News Bureau 116

Syngene International Q3 FY26 Revenue Slips Three Percent; Profit Impacted by One-Off Gratuity Provision

Syngene International Q3 FY26 Revenue Slips Three Percent; Profit Impacted by One-Off Gratuity Provision

Syngene International reported a muted financial performance for the third quarter of FY26, with consolidated revenue declining three percent year on year to INR nine hundred thirty two crore, compared with INR nine hundred sixty two crore in the same quarter last year. Profit after tax, before exceptional items, stood at INR seventy three crore.

Syngene International | 23/01/2026 | By Darshana 504

Syngene Renews Long-Term Research Alliance with Bristol Myers Squibb Until 2035

Syngene Renews Long-Term Research Alliance with Bristol Myers Squibb Until 2035

Syngene International has extended its long-term research collaboration with Bristol Myers Squibb until 2035, expanding the partnership to cover integrated services across the drug development lifecycle, from discovery and translational sciences to manufacturing, clinical trials and commercialisation support.

Syngene International | 20/01/2026 | By News Bureau

Syngene International Announces Plans to Add Bioconjugation Suite for End-To-End Antibody-Drug Conjugates Development

Syngene International Announces Plans to Add Bioconjugation Suite for End-To-End Antibody-Drug Conjugates Development

With this new capability, Syngene will offer fully integrated, end-to-end services for antibody-drug conjugates (ADCs) – from discovery through to GMP manufacturing – placing it among a handful of CDMOs with full-service capabilities.

Syngene International | 24/10/2025 | By Darshana 208

Syngene International Invests in Peptide Laboratory and Advanced Automation

Syngene International Invests in Peptide Laboratory and Advanced Automation

Syngene International has set up a dedicated peptide laboratory equipped with advanced automation technologies to accelerate hit-to-lead timelines. The investment enhances the company’s integrated drug discovery and development capabilities, reinforcing its position as a leading partner for end-to-end research solutions.

Syngene International | 16/10/2025 | By Dineshwori 282

Syngene Rolls Out New Platform for Enhanced Protein Production

Syngene Rolls Out New Platform for Enhanced Protein Production

Syngene International Ltd. has introduced its new protein production platform.

Syngene International | 05/06/2024 | By Aishwarya 701


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members